The new oncology committee will include: Jason Hafron, MD, DDS, PhD, MPH; and Pradeep Tyagi, PhD, MBA
Transaction supports Company’s continued execution of its product roadmap and capital expenditures for new equipment
Company outlines vision for building long-term shareholder growth